Boehringer Ingelheim and Click Therapeutics expand their existing Collaboration to develop Prescription Digital Therapeutics for Schizophrenia
December 19, 2022 08:00 AM Eastern Standard Time INGELHEIM, Germany & NEW YORK--(BUSINESS WIRE)--Boehringer Ingelheim and Click Therapeutics today announced the launch of an expanded…